Authors: Weggen, S Eriksen, JL Das, P Sagi, SA Wang, R Pietrzik, CU Findlay, KA Smith, TW Murphy, MP Butler, T Kang, DE Marquez-Sterling, N Golde, TE Koo, EH

Citation: S. Weggen et al., A subset of NSAIDs lower amyloidogenic A beta 42 independently of cyclooxygenase activity, NATURE, 414(6860), 2001, pp. 212-216

Authors: Soriano, S Kang, DE Fu, MF Pestell, R Chevallier, N Zheng, H Koo, EH

Citation: S. Soriano et al., Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein andNotch processing, J CELL BIOL, 152(4), 2001, pp. 785-794

Authors: Soriano, S Kang, DE Chevallier, N Zheng, H Koo, EH

Citation: S. Soriano et al., Functional consequences of the association of PS1 with beta-catenin, ALZHEIMER'S DISEASE, 2001, pp. 541-548

Authors: Van Uden, E Kang, DE Hoo, EH Masliah, E

Citation: E. Van Uden et al., LDL receptor-related protein (LRP) in Alzheimer's disease: Towards a unified theory of pathogenesis, MICROSC RES, 50(4), 2000, pp. 268-272

Authors: Kang, DE Pietrzik, CU Baum, L Chevallier, N Merriam, DE Kounnas, MZ Wagner, SL Troncoso, JC Kawas, CH Katzman, R Koo, EH

Citation: De. Kang et al., Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway, J CLIN INV, 106(9), 2000, pp. 1159-1166

Authors: Kang, DE Soriano, S Frosch, MP Collins, T Naruse, S Sisodia, SS Leibowitz, G Levine, F Koo, EH

Citation: De. Kang et al., Presenilin 1 facilitates the constitutive turnover of beta-catenin: Differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway, J NEUROSC, 19(11), 1999, pp. 4229-4237